|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113.80 INR | -1.04% |
|
-5.17% | +58.30% |
| 05-21 | Dubai Investments says Globalpharma signs 7 strategic MoUs | RE |
| 05-20 | ZIM Laboratories Limited, Q4 2026 Earnings Call, May 20, 2026 |
| Market Cap | 6.09B 63.88M 55.44M 51.58M 47.39M 89.56M 90.99M 607M 239M 3.03B 240M 235M 10.16B | P/E 2025 |
32.1x | P/E 2026 | 50.3x |
|---|---|---|---|---|---|
| Enterprise Value | 6.96B 72.93M 63.29M 58.88M 54.1M 102M 104M 694M 273M 3.46B 274M 268M 11.6B | EV / Sales 2025 |
1.34x | EV / Sales 2026 | 1.09x |
| Free-Float |
28.79% | Yield 2025 * |
-
| Yield 2026 | - |
Last Transcript: ZIM Laboratories Limited
| 1 day | -1.04% | ||
| 1 week | -5.17% | ||
| 1 month | -8.45% | ||
| 3 months | +29.29% | ||
| 6 months | +59.58% | ||
| Current year | +58.30% |
| 1 week | 112.95 | 120 | |
| 1 month | 111.5 | 125.5 | |
| Current year | 59.72 | 133.95 | |
| 1 year | 59.72 | 133.95 | |
| 3 years | 59.72 | 151.75 | |
| 5 years | 36.37 | 151.75 | |
| 10 years | 14 | 151.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CEO | Chief Executive Officer | - | 31/12/2001 |
| Director of Finance/CFO | - | 31/03/2019 | |
| Director of Finance/CFO | - | 31/12/1990 |
| Director | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CHM | Chairman | - | 31/12/1989 |
| Director/Board Member | - | 31/12/1990 | |
Prakash Sapkal
BRD | Director/Board Member | - | 31/12/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.04% | -5.17% | +3.27% | -17.98% | 63.84M | ||
| -0.53% | +2.54% | +16.63% | +74.09% | 50.03B | ||
| -1.81% | -0.49% | +51.99% | +112.44% | 36.6B | ||
| +0.46% | +4.44% | -5.24% | +25.38% | 12.47B | ||
| +1.05% | +1.63% | +16.19% | +78.22% | 11.77B | ||
| -1.33% | -0.76% | +30.08% | +131.70% | 9.04B | ||
| -2.99% | -2.09% | +41.02% | -8.36% | 7.03B | ||
| +0.51% | +1.46% | +12.17% | +32.88% | 6.79B | ||
| -.--% | +0.14% | - | - | 6.79B | ||
| +1.99% | +1.91% | +4.68% | +183.54% | 6.6B | ||
| Average | -0.37% | +0.38% | +18.98% | +67.99% | 14.72B | |
| Weighted average by Cap. | -0.62% | +1.27% | +25.17% | +82.80% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.79B 39.74M 34.49M 32.09M 29.49M 55.72M 56.61M 378M 149M 1.89B 149M 146M 6.32B | 3.74B 39.25M 34.06M 31.69M 29.12M 55.03M 55.9M 373M 147M 1.86B 147M 144M 6.24B |
| Net income | 122M 1.28M 1.11M 1.03M 946K 1.79M 1.82M 12.13M 4.77M 60.59M 4.79M 4.68M 203M | 58.38M 612K 531K 494K 454K 858K 872K 5.82M 2.29M 29.08M 2.3M 2.25M 97.35M |
| Net Debt | 1.16B 12.14M 10.53M 9.8M 9M 17.01M 17.28M 115M 45.38M 577M 45.57M 44.57M 1.93B | 863M 9.05M 7.85M 7.31M 6.71M 12.68M 12.89M 86.04M 33.83M 430M 33.98M 33.23M 1.44B |
Employees
632
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | ₹113.80 | -1.04% | 1,157 |
| 30/07/26 | ₹115.00 | +1.68% | 2,000 |
| 29/07/26 | ₹113.10 | -1.87% | 636 |
| 28/07/26 | ₹115.25 | -2.00% | 536 |
| 27/07/26 | ₹117.60 | -2.00% | 995 |
- Stock Market
- Stocks
- ZIMLAB Stock
Select your edition
All financial news and data tailored to specific country editions

















